Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lipitor Generic Bottleneck Needs To Be Cleared "Now," Senators Tells FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Without suggesting a specific action, five Democratic senators urge a "timely action" from FDA on "previous filings."
Advertisement

Related Content

Lipitor Generics: Ranbaxy Still In The Driver's Seat As Court Dismisses Mylan Lawsuit Against U.S. FDA
Lipitor Generics: Questions About Mylan's ANDA Weigh Heavily In Court's Dismissal Of Lawsuit Against FDA
Lipitor Generics: Questions About Mylan's ANDA Weigh Heavily In Court's Dismissal Of Lawsuit Against FDA
Lipitor Generics Problem Illustrates Need For Hatch-Waxman Reform, Academics Say
Lipitor Generics Problem Illustrates Need For Hatch-Waxman Reform, Academics Say
Mylan Sues FDA Alleging Inaction And Failure To Share Clarity On Ranbaxy's Atorvastatin Filings
Mylan Lawsuit Seeks To Force FDA's Hand On Lipitor Generics
Mylan Lawsuit Seeks To Force FDA's Hand On Lipitor Generics
The Last Days Of Lipitor: Morass Of Regulatory, Legal Issues Could Mean Few Early Generics
The Last Days Of Lipitor: Morass Of Regulatory, Legal Issues Could Mean Few Early Generics

Topics

Advertisement
UsernamePublicRestriction

Register

PS071936

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel